What is DD?

due dil·i·gence (“DD”)
  1.  A comprehensive appraisal of a business undertaken by a prospective buyer, especially to establish its assets and liabilities and evaluate its commercial potential.
  2.  The way to actually make money on the stock market.

    phase 3

    The final stage of clinical testing in the FDA’s New Drug Application process.

Phase 3 DD: We do the work so you don’t have to.

We specialize in analyzing biotech companies that are designing new drugs. Small biotech companies are typically great opportunities for investment. As they test their drugs, they approach what’s called a “binary event”: Pass or fail. Go or no-go. Get rich or go bankrupt.

If a biotech’s new drug is cleared by the FDA, the stock of the company usually skyrockets. If the drug fails the clinical trials, on the other hand… Well, the good news is that a stock price can’t actually go below zero.

In short, binary events are perfect for high-risk, high-reward investing. But how to tell whether a biotech will perform? Read the analysis or just scroll down to the bottom.

Sometimes we analyze financials. Sometimes we analyze the market. We always analyze the science. And while we’re not always right, we’re correct more often than not.

Mostly updates come on weekends.